AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock
91.2 NOK
-0.9 (-0.98%)
Taking everything into account, AKBM scores 4 out of 10 in our fundamental rating. AKBM was compared to 59 industry peers in the Food Products industry. There are concerns on the financial health of AKBM while its profitability can be described as average. AKBM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year AKBM was profitable.
AKBM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.
Of the past 5 years AKBM 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AKBM (44.73%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 115.79%, AKBM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
AKBM has a Return On Invested Capital of 1.30%. This is in the lower half of the industry: AKBM underperforms 76.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 44.73% | ||
| ROE | 115.79% | ||
| ROIC | 1.3% |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 67.04%, AKBM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin of AKBM (2.05%) is worse than 72.88% of its industry peers.
The Gross Margin of AKBM (43.26%) is better than 62.71% of its industry peers.
In the last couple of years the Gross Margin of AKBM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.05% | ||
| PM (TTM) | 67.04% | ||
| GM | 43.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKBM is destroying value.
AKBM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AKBM has about the same amount of shares outstanding.
The debt/assets ratio for AKBM has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.56, we must say that AKBM is in the distress zone and has some risk of bankruptcy.
AKBM has a worse Altman-Z score (1.56) than 69.49% of its industry peers.
AKBM has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
AKBM's Debt to Equity ratio of 1.06 is on the low side compared to the rest of the industry. AKBM is outperformed by 72.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.56 |
ROIC/WACC0.15
WACC8.52%
2.3 Liquidity
A Current Ratio of 2.62 indicates that AKBM has no problem at all paying its short term obligations.
The Current ratio of AKBM (2.62) is better than 88.14% of its industry peers.
A Quick Ratio of 1.25 indicates that AKBM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.25, AKBM is in the better half of the industry, outperforming 77.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.25 |
3. Growth
3.1 Past
AKBM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15747.24%, which is quite impressive.
The Revenue for AKBM has decreased by -15.34% in the past year. This is quite bad
The Revenue has been decreasing by -4.17% on average over the past years.
EPS 1Y (TTM)15747.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%-41.17%
3.2 Future
Based on estimates for the next years, AKBM will show a very strong growth in Earnings Per Share. The EPS will grow by 96.03% on average per year.
The Revenue is expected to grow by 20.59% on average over the next years. This is a very strong growth
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 4.54, the valuation of AKBM can be described as very cheap.
Based on the Price/Earnings ratio, AKBM is valued cheaper than 96.61% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. AKBM is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 37.36 indicates a quite expensive valuation of AKBM.
AKBM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AKBM is more expensive than 74.58% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKBM to the average of the S&P500 Index (23.56), we can say AKBM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.54 | ||
| Fwd PE | 37.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKBM indicates a slightly more expensive valuation: AKBM is more expensive than 74.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.01 |
4.3 Compensation for Growth
AKBM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AKBM's earnings are expected to grow with 96.03% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y117.56%
EPS Next 3Y96.03%
5. Dividend
5.1 Amount
AKBM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:AKBM (12/8/2025, 7:00:00 PM)
91.2
-0.9 (-0.98%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners7%
Inst Owner ChangeN/A
Ins Owners3.22%
Ins Owner ChangeN/A
Market Cap8.00B
Revenue(TTM)258.20M
Net Income(TTM)173.10M
Analysts77.78
Price Target86.7 (-4.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend42.97
Dividend Growth(5Y)N/A
DP215.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.25%
EPS NY rev (3m)-15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.54 | ||
| Fwd PE | 37.36 | ||
| P/S | 3.06 | ||
| P/FCF | N/A | ||
| P/OCF | 192.91 | ||
| P/B | 5.29 | ||
| P/tB | 28.87 | ||
| EV/EBITDA | 21.01 |
EPS(TTM)20.1
EY22.04%
EPS(NY)2.44
Fwd EY2.68%
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)0.47
OCFY0.52%
SpS29.77
BVpS17.24
TBVpS3.16
PEG (NY)0.06
PEG (5Y)N/A
Graham Number88.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 44.73% | ||
| ROE | 115.79% | ||
| ROCE | 1.69% | ||
| ROIC | 1.3% | ||
| ROICexc | 1.39% | ||
| ROICexgc | 2.38% | ||
| OM | 2.05% | ||
| PM (TTM) | 67.04% | ||
| GM | 43.26% | ||
| FCFM | N/A |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.5 | ||
| Cap/Depr | 48.25% | ||
| Cap/Sales | 7.47% | ||
| Interest Coverage | 0.39 | ||
| Cash Conversion | 9.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.25 | ||
| Altman-Z | 1.56 |
F-Score5
WACC8.52%
ROIC/WACC0.15
Cap/Depr(3y)77.43%
Cap/Depr(5y)88.04%
Cap/Sales(3y)14.31%
Cap/Sales(5y)16.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15747.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%-41.17%
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
EBIT growth 1Y60.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year170.83%
EBIT Next 3Y67.11%
EBIT Next 5YN/A
FCF growth 1Y62.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.58%
OCF growth 3Y155.79%
OCF growth 5Y-0.17%
AKER BIOMARINE ASA / AKBM.OL FAQ
Can you provide the ChartMill fundamental rating for AKER BIOMARINE ASA?
ChartMill assigns a fundamental rating of 4 / 10 to AKBM.OL.
What is the valuation status for AKBM stock?
ChartMill assigns a valuation rating of 4 / 10 to AKER BIOMARINE ASA (AKBM.OL). This can be considered as Fairly Valued.
What is the profitability of AKBM stock?
AKER BIOMARINE ASA (AKBM.OL) has a profitability rating of 4 / 10.
What are the PE and PB ratios of AKER BIOMARINE ASA (AKBM.OL) stock?
The Price/Earnings (PE) ratio for AKER BIOMARINE ASA (AKBM.OL) is 4.54 and the Price/Book (PB) ratio is 5.29.
What is the financial health of AKER BIOMARINE ASA (AKBM.OL) stock?
The financial health rating of AKER BIOMARINE ASA (AKBM.OL) is 3 / 10.